China approves first inhaler covid-19 vaccine
An inhalable COVID-19 vaccine has been approved by Chinese government for use in the country.
The vaccine which is the first inhalable COVID-19 vaccine was developed by the Tianjin-based manufacturer, CanSino Biologics and approved the Chinese government for emergency use.
According to Reuters, the approval boosted Cansino’s share price by seven per cent on Monday.
While other vaccines have been administered through injections, the new needle-free vaccine can be stored and administered easily through a nebuliser, according to the company.
“The approval will have a positive impact on the company’s performance if the vaccine is subsequently purchased and used by relevant government agencies,” CanSino said.
The company also said it was uncertain when its vaccine would be able to go to market since additional administrative approvals are still needed.
China has so far approved eight other locally manufactured injectable vaccines since 2020.
According to WHO, over 3.4 billion COVID-19 vaccine doses have been administered as of 31 August.